Association Between Pseudoexfoliation Syndrome and Diabetes Mellitus

Assiut University

Status: Unknown

Conditions: Lens Diseases

Treatments: Device: slit lamp

Study type: Observational

Funder types: Other

Identifiers

NCT03741153

PXSDM

Details and patient eligibility

About

Pseudoexfoliation syndrome (PEX) is characterized by the deposition of a distinctive fibrillar material in the anterior segment of the eye and was first described in 1917 by Lindberg. It is frequently associated with open angle glaucoma, known as pseudoexfoliation glaucoma, which is one of the most common identifiable forms of secondary open angle glaucoma worldwide. Despite extensive research, the exactchemical nature of the fibrillar material is unknown. It is believed to be secreted multifocally in the iris pigment epithelium, the ciliary epithelium, and the peripheral anterior lens epithelium.

Enrollment: 100 estimated patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Phakic patients presenting to Ophthalmology outpatient clinic Of Assiut University Hospital.

Exclusion criteria

• Patients with previous intraocular surgery.

Trial design

100 participants in 2 patient groups

study group

Description:

includes patients who will be diagnosed with Pseudoexfoliation syndrome

Treatment:

Device: slit lamp

control group

Description:

age matched controls who do not have Pseudoexfoliation syndrome

Treatment:

Device: slit lamp